Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
31.43M
Enterprise Value
8.14M
Income
-116.81M
Sales
15.63M
Book/sh
1.03
Cash/sh
0.39
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
197
IPO
Aug 21, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
2.01
P/B
0.39
P/C
1.01
P/FCF
-
EV/EBITDA
-
EV/Sales
0.52
Quick Ratio
2.59
Current Ratio
2.84
Debt/Eq
0.11
LT Debt/Eq
0.05
Option/Short
Yes / Yes
EPS (ttm)
-1.71
EPS next Y
-0.45
EPS next Q
-0.15
EPS this Y
-8.91%
EPS next Y
64.12%
EPS next 5Y
38.74%
EPS past 3/5Y
18.87% 1.18%
Sales past 3/5Y
14.93% -
EPS Y/Y TTM
-89.07%
Sales Y/Y TTM
31.52%
EPS Q/Q
-244.36%
Sales Q/Q
36.71%
Insider Own
7.37%
Insider Trans
4.19%
Inst Own
12.30%
Inst Trans
-13.44%
ROA
-84.82%
ROE
-98.98%
ROIC
-153.10%
Gross Margin
-79.87%
Oper. Margin
-387.33%
Profit Margin
-747.20%
SMA20
-25.31%
SMA50
-42.32%
SMA200
-75.98%
Trades
Shs Outstand
78.59M
Shs Float
72.79M
52W High
4.70 -91.50%
52W Low
0.36 11.08%
Volatility
13.96% 9.13%
ATR (14)
0.05
RSI (14)
24.47
Beta
1.32
Rel Volume
0.12
Avg Volume
1.14M
Volume
6,988
Perf Week
-11.70%
Perf Month
-39.53%
Perf Quarter
-54.86%
Perf Half Y
-76.95%
Perf YTD
-85.72%
Perf Year
-90.22%
Perf 3Y
-92.73%
Perf 5Y
-98.24%
Perf 10Y
-
Prev Close
0.38
Price
0.40
Change %
4.28%
Date Action Analyst Rating Change Price Target Change
Jul-07-26Downgrade Alliance Global Partners Buy → Neutral $3
Jan-06-25Initiated D. Boral Capital Buy $23
Sep-08-23Initiated Alliance Global Partners Buy $14.50
Jan-05-23Initiated Cantor Fitzgerald Overweight $21
Apr-19-21Initiated Ladenburg Thalmann Buy $52
Sep-15-20Initiated Oppenheimer Perform
Sep-15-20Initiated Cantor Fitzgerald Overweight $70
Sep-15-20Initiated Berenberg Buy $65
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meltzer ErezChief Executive OfficerOct 19 '26Buy0.4525,00011,25090,443Oct 20 06:01 AM
Meltzer ErezChief Executive OfficerSep 15 '26Buy0.6910,0006,90065,443Sep 16 06:14 AM
Suesskind Dan SDirectorSep 14 '26Buy0.7660,00045,300110,000Sep 15 08:00 AM
Meltzer ErezChief Executive OfficerSep 10 '26Buy0.7810,0007,80055,443Sep 14 07:59 AM
Meltzer ErezChief Executive OfficerAug 10 '26Buy1.039,4439,72645,443Aug 11 09:24 AM
Daniel RanOfficerAug 03 '26Proposed Sale0.985,9505,831Aug 04 08:51 AM
Suesskind Dan SDirectorJul 27 '26Buy0.9350,00046,50050,000Jul 29 07:40 AM
Kainan NogaDirectorJul 28 '26Buy0.9033,00029,70040,792Jul 29 07:35 AM
Daniel RanOfficerJul 30 '26Proposed Sale0.881,000880Jul 28 09:37 PM
Meltzer ErezChief Executive OfficerJul 27 '26Buy0.9336,00033,48036,000Jul 28 04:54 PM
Alroy ErezDirectorJun 10 '26Sale1.656781,1196,753Jun 15 04:05 PM
Nano-X Imaging Ltd. engages in the development of medical imaging systems. It operates through the following segments: Nanox.Arc, AI Solutions, and Radiology Services. Its product Nanox System consists of hardware Nanox.ARC and software Nanox.CLOUD that provides image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive artificial intelligence systems, billing, and reporting. The company was founded by Ran Poliakine and Hitoshi Masuya in 2011 and is headquartered in Petach Tikva, Israel.
CEO & Acting Chairman of the BoardMr. Erez I. Z. Meltzer
Executive VP & Chief Marketing OfficerMs. Tamar Aharon Cohen
GM of Source & Services Division and Head of Nanox USAMr. James M. Dara
Chief Financial OfficerMr. Guy Nathanzon
Chief Legal OfficerMs. Marina Gofman Feler
BFLY Butterfly Network Inc daily Stock Chart
Index
RUT
Market Cap
1.85B
Enterprise Value
1.74B
Income
-74.85M
Sales
112.14M
Book/sh
0.72
Cash/sh
0.46
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
220
IPO
Jul 13, 2020
P/E
-
Forward P/E
-
PEG
-
P/S
16.50
P/B
9.52
P/C
14.84
P/FCF
-
EV/EBITDA
-
EV/Sales
15.56
Quick Ratio
3.02
Current Ratio
4.06
Debt/Eq
0.10
LT Debt/Eq
0.09
Option/Short
Yes / Yes
EPS (ttm)
-0.29
EPS next Y
-0.07
EPS next Q
-0.04
EPS this Y
10.45%
EPS next Y
31.83%
EPS next 5Y
73.83%
EPS past 3/5Y
28.25% 58.99%
Sales past 3/5Y
9.97% 16.11%
EPS Y/Y TTM
-5.15%
Sales Y/Y TTM
28.14%
EPS Q/Q
11.49%
Sales Q/Q
39.47%
Insider Own
20.32%
Insider Trans
-19.70%
Inst Own
63.97%
Inst Trans
19.70%
ROA
-25.11%
ROE
-35.46%
ROIC
-36.39%
Gross Margin
52.64%
Oper. Margin
-60.03%
Profit Margin
-66.74%
SMA20
-15.90%
SMA50
-17.40%
SMA200
14.15%
Trades
Shs Outstand
238.00M
Shs Float
216.15M
52W High
10.21 -33.20%
52W Low
1.90 258.95%
Volatility
6.04% 7.00%
ATR (14)
0.55
RSI (14)
36.77
Beta
2.14
Rel Volume
0.01
Avg Volume
5.60M
Volume
4,142
Perf Week
-5.93%
Perf Month
-27.52%
Perf Quarter
-3.54%
Perf Half Y
27.95%
Perf YTD
79.47%
Perf Year
207.21%
Perf 3Y
727.37%
Perf 5Y
-34.17%
Perf 10Y
-
Prev Close
6.81
Price
6.82
Change %
0.15%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DEVIVO JOSEPHPresident & CEOOct 06 '26Sale10.0235,790358,6167,311,930Oct 08 05:55 PM
Carlson MeganCAO and SVP, FinanceOct 02 '26Sale8.7410,11488,447401,971Oct 06 04:36 PM
DEVIVO JOSEPHOfficerOct 06 '26Proposed Sale10.0235,790358,615Oct 06 02:39 PM
Carlson MeganOfficerOct 02 '26Proposed Sale8.7510,11488,448Oct 02 04:54 PM
DEVIVO JOSEPHPresident & CEOSep 23 '26Sale10.023,16931,7577,347,720Sep 24 05:50 PM
DEVIVO JOSEPHPresident & CEOSep 22 '26Sale10.002,81128,1107,350,889Sep 24 05:50 PM
DEVIVO JOSEPHOfficerSep 23 '26Proposed Sale10.023,16931,757Sep 23 04:32 PM
Schwartz EricaFormer DirectorSep 23 '26Proposed Sale10.00323,0203,230,200Sep 23 11:01 AM
DEVIVO JOSEPHOfficerSep 22 '26Proposed Sale10.002,81128,110Sep 22 05:00 PM
Schwartz EricaFormer DirectorSep 22 '26Proposed Sale10.0078,679786,790Sep 22 04:51 PM
Cashman SteveChief Business OfficerSep 04 '26Sale7.30140,1121,023,0981,490,295Sep 09 04:45 PM
Carlson MeganCAO and SVP, FinanceSep 04 '26Sale7.3013,804100,797412,085Sep 09 04:42 PM
Caezza NicholasDeputy General CounselSep 02 '26Sale8.151,70913,927305,166Sep 04 04:20 PM
Cashman SteveOfficerSep 04 '26Proposed Sale7.30140,1121,023,056Sep 04 03:46 PM
Carlson MeganOfficerSep 04 '26Proposed Sale7.3013,804100,793Sep 04 03:29 PM
Caezza NicholasOfficerSep 02 '26Proposed Sale8.151,70913,927Sep 02 03:45 PM
ROBBINS LARRYDirectorAug 13 '26Sale9.24890,5338,224,6884,371,387Aug 17 07:01 PM
ROBBINS LARRYDirectorAug 14 '26Sale8.70824,7007,172,6633,546,687Aug 17 07:01 PM
ROBBINS LARRYDirectorAug 17 '26Sale8.97582,5005,225,1422,964,187Aug 17 07:01 PM
Phanstiel S. LouiseDirectorAug 14 '26Buy8.68115,200999,510300,461Aug 17 04:51 PM
Caezza NicholasDeputy General CounselAug 11 '26Sale9.7510,00097,500300,307Aug 12 05:03 PM
DEVIVO JOSEPHPresident & CEOAug 10 '26Sale10.0168,346684,0757,603,700Aug 12 04:32 PM
Caezza NicholasOfficerAug 11 '26Proposed Sale9.7510,00097,500Aug 11 01:46 PM
DEVIVO JOSEPHOfficerAug 10 '26Proposed Sale10.0168,346684,082Aug 10 04:44 PM
Carfora DawnOfficerAug 10 '26Proposed Sale9.758,77085,512Aug 10 11:24 AM
Carlson MeganCAO and SVP, FinanceJul 31 '26Sale7.8668,852541,383425,889Aug 04 04:41 PM
ROBBINS LARRYDirectorJul 31 '26Sale7.391,720,12912,716,05412,614,926Aug 03 06:11 PM
ROBBINS LARRYDirectorAug 03 '26Sale8.10156,1631,265,67012,458,763Aug 03 06:11 PM
ROBBINS LARRYDirectorJul 31 '26Proposed Sale7.111,876,29213,340,436Jul 31 09:46 PM
Carlson MeganOfficerJul 31 '26Proposed Sale7.8668,852541,406Jul 31 11:40 AM
ROTHBERG JONATHAN MDirectorJul 22 '26Sale6.47659,9134,269,5050Jul 24 04:57 PM
ROTHBERG JONATHAN MDirectorJul 22 '26Proposed Sale6.47659,9134,270,000Jul 22 06:08 PM
ROTHBERG JONATHAN MDirectorJul 17 '26Sale6.601,195,8577,887,75354,143Jul 21 07:52 PM
ROTHBERG JONATHAN MDirectorJul 20 '26Sale6.611,177,2767,786,26872,724Jul 21 07:52 PM
ROTHBERG JONATHAN MDirectorJul 21 '26Sale6.74753,3205,074,288496,680Jul 21 07:52 PM
ROTHBERG JONATHAN MDirectorJul 21 '26Proposed Sale6.73753,3205,070,000Jul 21 04:59 PM
Ku VictorChief Technology OfficerJul 20 '26Sale6.5648,540318,4221,015,099Jul 21 04:26 PM
Doherty John N.EVP, CFOJul 20 '26Sale6.5657,136374,8121,397,276Jul 21 04:23 PM
DEVIVO JOSEPHPresident & CEOJul 20 '26Sale6.56211,7981,389,3957,672,046Jul 21 04:21 PM
ROTHBERG JONATHAN MDirectorJul 20 '26Proposed Sale6.621,177,2767,790,000Jul 20 05:09 PM
Doherty John N.OfficerJul 20 '26Proposed Sale6.5617Jul 20 04:20 PM
DEVIVO JOSEPHOfficerJul 20 '26Proposed Sale6.56211,7981,389,353Jul 20 03:12 PM
Doherty John N.OfficerJul 20 '26Proposed Sale6.5657,135374,794Jul 20 03:10 PM
Ku VictorOfficerJul 20 '26Proposed Sale6.5648,540318,413Jul 20 03:10 PM
ROTHBERG JONATHAN MDirectorJul 17 '26Proposed Sale6.591,195,8577,880,000Jul 17 04:48 PM
ROTHBERG JONATHAN MDirectorJul 15 '26Sale7.321,730,31912,670,780359,748Jul 16 08:18 PM
ROTHBERG JONATHAN MDirectorJul 16 '26Sale7.091,213,6348,603,33036,366Jul 16 08:18 PM
ROTHBERG JONATHAN MDirectorJul 14 '26Sale7.72815,6326,294,8852,090,067Jul 16 08:18 PM
ROTHBERG JONATHAN MDirectorJul 16 '26Sale7.09253,8671,799,638105,881Jul 16 08:18 PM
ROTHBERG JONATHAN MDirectorJul 16 '26Proposed Sale7.091,467,50110,400,000Jul 16 05:43 PM
ROTHBERG JONATHAN MDirectorJul 15 '26Proposed Sale7.321,730,31912,670,000Jul 15 05:39 PM
ROTHBERG JONATHAN MDirectorJul 14 '26Proposed Sale7.71815,6326,290,000Jul 14 05:57 PM
Ku VictorChief Technology OfficerJul 07 '26Sale7.8735,649280,6651,063,639Jul 08 04:32 PM
Doherty John N.EVP, CFOJul 07 '26Sale7.8755,229434,8181,454,412Jul 08 04:29 PM
DEVIVO JOSEPHPresident & CEOJul 07 '26Sale7.87204,7251,611,8007,883,844Jul 08 04:25 PM
Carlson MeganCAO and SVP, FinanceJul 02 '26Sale7.9641,303328,937465,906Jul 07 04:10 PM
DEVIVO JOSEPHOfficerJul 07 '26Proposed Sale7.87204,7251,611,820Jul 07 03:22 PM
Ku VictorOfficerJul 07 '26Proposed Sale7.8735,649280,668Jul 07 03:17 PM
Doherty John N.OfficerJul 07 '26Proposed Sale7.8755,229434,823Jul 07 03:09 PM
Carlson MeganOfficerJul 02 '26Proposed Sale7.9641,303328,916Jul 02 03:09 PM
Carfora DawnOfficerJun 29 '26Proposed Sale9.33176,3011,644,607Jun 29 04:27 PM
Carfora DawnDirectorJun 22 '26Proposed Sale8.2280,434660,930Jun 22 10:24 AM
Cashman SteveChief Business OfficerJun 08 '26Sale4.66294,6801,373,2091,630,407Jun 09 05:19 PM
Cashman SteveChief Business OfficerJun 05 '26Sale4.96104,781520,1331,925,087Jun 09 05:19 PM
Cashman SteveOfficerJun 08 '26Proposed Sale4.69184,680865,448Jun 08 01:06 PM
Cashman SteveOfficerJun 08 '26Proposed Sale4.62110,000507,876Jun 08 12:30 PM
Cashman SteveOfficerJun 05 '26Proposed Sale4.96104,781520,174Jun 05 04:17 PM
Caezza NicholasDeputy General CounselJun 02 '26Sale4.521,7337,831310,307Jun 04 04:02 PM
Caezza NicholasOfficerJun 02 '26Proposed Sale4.521,7337,831Jun 02 03:17 PM
Carlson MeganCAO and SVP, FinanceMay 01 '26Sale4.75110,422524,394507,209May 05 04:05 PM
Cashman SteveChief Business OfficerApr 29 '26Sale4.91147,518724,1662,029,868May 01 04:04 PM
Carlson MeganOfficerMay 01 '26Proposed Sale4.75110,422524,402May 01 02:04 PM
Cashman SteveOfficerApr 29 '26Proposed Sale4.91147,518724,151Apr 29 03:42 PM
Cashman SteveChief Business OfficerApr 16 '26Sale5.22200,0001,044,4002,177,386Apr 17 04:02 PM
Cashman SteveOfficerApr 16 '26Proposed Sale5.22200,0001,044,483Apr 16 04:14 PM
DEVIVO JOSEPHPresident & CEOMar 05 '26Sale3.71482,1491,788,2918,030,899Mar 06 04:05 PM
DEVIVO JOSEPHOfficerMar 05 '26Proposed Sale3.71482,1491,788,484Mar 05 04:42 PM
Cashman SteveChief Business OfficerMar 03 '26Sale3.7142,540157,9082,377,386Mar 04 04:11 PM
DEVIVO JOSEPHPresident & CEOMar 03 '26Sale3.71161,275598,6538,513,048Mar 04 04:11 PM
Caezza NicholasDeputy General CounselMar 03 '26Sale3.7114,20952,744312,040Mar 04 04:11 PM
Carlson MeganCAO and SVP, FinanceMar 03 '26Sale3.7141,978155,822617,631Mar 04 04:11 PM
Carlson MeganOfficerMar 03 '26Proposed Sale3.7141,978155,831Mar 03 04:58 PM
DEVIVO JOSEPHOfficerMar 03 '26Proposed Sale3.71161,275598,685Mar 03 04:54 PM
Caezza NicholasOfficerMar 03 '26Proposed Sale3.7114,20952,747Mar 03 04:11 PM
Cashman SteveOfficerMar 03 '26Proposed Sale3.7142,540157,917Mar 03 03:57 PM
Cashman SteveChief Business OfficerFeb 26 '26Sale4.35250,0001,087,0001,931,884Mar 02 04:23 PM
Cashman SteveOfficerFeb 26 '26Proposed Sale4.35250,0001,087,050Feb 26 04:25 PM
Doherty John N.EVP, CFOJan 07 '26Sale3.9860,182239,5241,234,688Jan 09 04:02 PM
ROTHBERG JONATHAN MDirectorJan 07 '26Sale4.14452,7291,874,253335,834Jan 08 06:14 PM
ROTHBERG JONATHAN MDirectorJan 06 '26Sale4.03351,6171,416,806788,563Jan 08 06:14 PM
ROTHBERG JONATHAN MDirectorJan 08 '26Sale4.18335,8341,404,5250Jan 08 06:14 PM
ROTHBERG JONATHAN MDirectorJan 08 '26Proposed Sale4.18335,8341,404,525Jan 08 04:53 PM
ROTHBERG JONATHAN MDirectorJan 07 '26Proposed Sale4.14452,7291,874,253Jan 07 04:49 PM
Ku VictorChief Technology OfficerJan 05 '26Sale3.8235,968137,398811,962Jan 07 04:06 PM
Doherty John N.OfficerJan 07 '26Proposed Sale3.9860,182239,494Jan 07 03:13 PM
ROTHBERG JONATHAN MDirectorJan 06 '26Proposed Sale4.03351,6171,416,805Jan 06 05:22 PM
Ku VictorOfficerJan 05 '26Proposed Sale3.8235,968137,416Jan 05 03:11 PM
ROTHBERG JONATHAN MDirectorDec 23 '25Sale4.0144,781179,4241,157,764Dec 29 04:05 PM
ROTHBERG JONATHAN MDirectorDec 26 '25Sale4.0114,91159,7901,140,180Dec 29 04:05 PM
ROTHBERG JONATHAN MDirectorDec 24 '25Sale4.002,67310,6921,155,091Dec 29 04:05 PM
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.
CEOMr. Joseph M. DeVivo
Founder & DirectorDr. Jonathan M. Rothberg Ph.D.
Executive VP & CFOMr. John N. Doherty
Executive VP & Chief Business OfficerMr. Steven Cashman
Chief Accounting Officer & Senior VP of Finance & AccountingMs. Megan Carlson
GEHC GE HealthCare Technologies Inc daily Stock Chart
Index
NDX, S&P 500
Market Cap
32.05B
Enterprise Value
40.73B
Income
1.99B
Sales
21.27B
Book/sh
24.30
Cash/sh
4.66
Employees
54000
IPO
Dec 15, 2022
P/E
16.30
Forward P/E
13.05
PEG
1.36
P/S
1.51
P/B
2.92
P/C
15.22
P/FCF
20.30
EV/EBITDA
11.54
EV/Sales
1.91
Quick Ratio
0.91
Current Ratio
1.21
Debt/Eq
0.96
LT Debt/Eq
0.95
Option/Short
Yes / Yes
EPS (ttm)
4.35
EPS next Y
5.44
EPS next Q
1.20
EPS this Y
7.24%
EPS next Y
10.44%
EPS next 5Y
9.60%
EPS past 3/5Y
2.53% 0.61%
Sales past 3/5Y
3.99% 3.74%
EPS Y/Y TTM
-11.06%
Sales Y/Y TTM
6.52%
EPS Q/Q
16.45%
Sales Q/Q
5.75%
Insider Own
0.32%
Insider Trans
7.73%
Inst Own
92.46%
Inst Trans
-1.35%
ROA
5.46%
ROE
19.19%
ROIC
9.28%
Gross Margin
39.37%
Oper. Margin
13.73%
Profit Margin
9.33%
SMA20
5.24%
SMA50
3.80%
SMA200
1.19%
Trades
Shs Outstand
451.69M
Shs Float
450.24M
52W High
89.77 -20.96%
52W Low
58.75 20.77%
Volatility
2.38% 2.40%
ATR (14)
1.82
RSI (14)
62.13
Beta
0.82
Rel Volume
0.03
Avg Volume
3.76M
Volume
5,060
Perf Week
1.98%
Perf Month
6.88%
Perf Quarter
16.08%
Perf Half Y
3.08%
Perf YTD
-13.50%
Perf Year
-8.17%
Perf 3Y
10.88%
Perf 5Y
-
Perf 10Y
-
Prev Close
71.42
Price
70.95
Change %
-0.66%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lobo KevinDirectorMay 22 '26Buy64.1810,000641,80014,363May 26 06:44 PM
Hochman Rodney FDirectorMay 12 '26Buy62.031,618100,3651,618May 13 04:19 PM
Yang Watkin Phoebe L.DirectorMay 08 '26Buy63.011,00063,00613,702May 11 08:16 PM
CULP H LAWRENCE JRDirectorMay 06 '26Buy61.8880,8055,000,076151,207May 07 04:14 PM
Stromberg William JDirectorMay 06 '26Buy61.691,00061,68915,330May 07 04:09 PM
SACCARO JAMESChief Financial OfficerMay 01 '26Buy60.603,310200,58587,471May 01 11:38 AM
Jimenez Frank RGC & Corporate SecretaryApr 30 '26Buy60.451,750105,78893,932Apr 30 04:21 PM
Arduini Peter JPresident and CEOApr 30 '26Buy59.924,169249,827259,424Apr 30 04:20 PM
Kenneth StacherskiFormer OfficerNov 24 '25Proposed Sale77.004,585353,045Nov 24 04:24 PM
Kenneth StacherskiFormer OfficerOct 27 '25Proposed Sale78.954,585361,993Oct 27 04:26 PM
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
PresidentMr. Peter J. Arduini
M.S.Dr. Taha Kass-Hout M.D.
General Counsel & Corporate SecretaryMr. Frank R. Jimenez Esq.
President & CEO of Patient Care SolutionsMs. Jeannette Bankes
Chief Financial OfficerMr. William K. Grogan